KEYNOTE024_2 | R Documentation |
Kaplan-Meier digitized data from KEYNOTE024, figure 2 (PMID 27718847). A reported sample size of 305 for a primary endpoint of PFS in lung cancer.
KEYNOTE024_2
A data frame of 305 observations and 3 variables:
time | event time (in months) | |
event | OS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (chemo, pembrolizumab) | |
Reck M, Rodríguez-Abreu D, Robinson AG, et al. Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. N Engl J Med 2016; 375: 1823–33.
summary(KEYNOTE024_2)
kmplot(KEYNOTE024_2)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.